Physician profile
Iain Matthew Bailey
NPI 1932631223
$4,657.29
in general payments reported to CMS, 2019-2025
18 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 82% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.00 · 2022: $429 · 2023: $1,246 · 2024: $1,297 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,743.04 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $384.43 | 2025 | Omnia, Senza |
| Nevro Corp. | $372.36 | 2022-2024 | Senza |
| Boston Scientific Corporation | $264.54 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Spinefrontier, INC. | $261.55 | 2024 | Inspan |
| Abbott Laboratories | $195.30 | 2022-2024 | Proclaim |
| Vertos Medical, INC. | $147.47 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $54.97 | 2022-2023 | Xtampza |
| Scilex Pharmaceuticals INC. | $36.09 | 2024-2025 | |
| Curonix LLC | $35.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $25.28 | 2023 | Exparel, Iovera, Zilretta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.18 | 2025 | Relistor |
| Alnylam Pharmaceuticals INC. | $23.14 | 2024 | Givlaari |
| Si-Bone, INC. | $21.81 | 2025 | |
| Amgen INC. | $20.04 | 2025 | Evenity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $20.03 | 2023 | Hymovis, Triluron |
| Painteq LLC | $15.12 | 2023 | Painteq |
| Orthofundamentals, LLC | $12.78 | 2025 | Trellis Si Joint Fusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iain Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.